Company: WHWK
Filing Date: 2025-03-31
Form Type: S-3
Source: 0001193125-25-068942
Chunk: 3

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-31
Form: S-3
Chunk 3
---
 prospectus from time to time by filing amendments or supplements as required. You should carefully read this prospectus and any
amendments or supplements accompanying this prospectus, together with any documents incorporated by reference herein or therein, before you make your investment decision.

The selling stockholders may sell any, all or none of the securities offered by this prospectus and we do not know when or in what amount the selling
stockholders may sell their common shares hereunder following the effective date of the registration statement of which this prospectus forms a part.

We
are a smaller reporting company as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As such, we have elected to rely on certain
reduced public company disclosure requirements. See “Implications of Being a Smaller Reporting Company.”

Our common stock is listed on The Nasdaq
Capital Market under the symbol “WHWK.” On March 28, 2025, the last reported sale price of our common stock was $1.91 per share.

Investing in our securities involves a high degree of risk. See “ Risk Factors” on page 5 of this prospectus and in the documents incorporated by reference in this prospectus, as updated in the applicable prospectus supplement, and other future filings we make with the Securities and Exchange Commission that are incorporated by reference into this prospectus, for a discussion of the factors you should consider carefully before deciding to purchase our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus is , 2025

TABLE OF CONTENTS

|                                                   |     | Page |    |
| PROSPECTUS SUMMARY                                |     |      |  1 |
| RISK FACTORS                                      |     |      |  5 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS |     |      |  6 |
| USE OF PROCEEDS                                   |     |      |  8 |
| SELLING STOCKHOLDERS                              |     |      |  9 |
| PLAN OF DISTRIBUTION                              |     |      | 14 |
| LEGAL MATTERS                                     |     |      | 16 |
| EXPERTS                                           |     |      | 16 |
| WHERE YOU CAN FIND ADDITIONAL INFORMATION         |     |